Literature DB >> 20869643

Dilated cardiomyopathy and heart failure in children.

Daphne T Hsu1, Charles E Canter.   

Abstract

This article describes the causes and outcomes of dilated cardiomyopathy in children. Genetic, infectious, metabolic, and acquired causes of dilated cardiomyopathy are discussed. The predictors for better and worse outcomes are reviewed. Guidelines for the use of medical and surgical therapies to treat heart failure in children are summarized.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20869643     DOI： 10.1016/j.hfc.2010.05.003

Source DB:  PubMed          Journal:  Heart Fail Clin        ISSN： 1551-7136            Impact factor:   3.179


  9 in total

1.  Early predictors of survival to and after heart transplantation in children with dilated cardiomyopathy.

Authors:  Biagio A Pietra; Paul F Kantor; Heather L Bartlett; Clifford Chin; Charles E Canter; Ranae L Larsen; R Erik Edens; Steven D Colan; Jeffrey A Towbin; Steven E Lipshultz; James K Kirklin; David C Naftel; Daphne T Hsu
Journal:  Circulation       Date:  2012-07-16       Impact factor: 29.690

2.  Survival Without Cardiac Transplantation Among Children With Dilated Cardiomyopathy.

Authors:  Rakesh K Singh; Charles E Canter; Ling Shi; Steven D Colan; Debra A Dodd; Melanie D Everitt; Daphne T Hsu; John L Jefferies; Paul F Kantor; Elfriede Pahl; Joseph W Rossano; Jeffrey A Towbin; James D Wilkinson; Steven E Lipshultz
Journal:  J Am Coll Cardiol       Date:  2017-11-28       Impact factor: 24.094

3.  Prevalence, predictors, and outcomes of cardiorenal syndrome in children with dilated cardiomyopathy: a report from the Pediatric Cardiomyopathy Registry.

Authors:  Ahmad Kaddourah; Stuart L Goldstein; Steven E Lipshultz; James D Wilkinson; Lynn A Sleeper; Minmin Lu; Steven D Colan; Jeffrey A Towbin; Scott I Aydin; Joseph Rossano; Melanie D Everitt; Jeffrey G Gossett; Paolo Rusconi; Paul F Kantor; Rakesh K Singh; John L Jefferies
Journal:  Pediatr Nephrol       Date:  2015-07-26       Impact factor: 3.714

4.  Variability of M-mode versus two-dimensional echocardiography measurements in children with dilated cardiomyopathy.

Authors:  Caroline K Lee; Renee Margossian; Lynn A Sleeper; Charles E Canter; Shan Chen; Lloyd Y Tani; Girish Shirali; Anita Szwast; Elif Seda Selamet Tierney; M Jay Campbell; Fraser Golding; Yanli Wang; Karen Altmann; Steven D Colan
Journal:  Pediatr Cardiol       Date:  2013-11-22       Impact factor: 1.655

5.  Predictors of disease progression in pediatric dilated cardiomyopathy.

Authors:  Kimberly M Molina; Peter Shrader; Steven D Colan; Seema Mital; Renee Margossian; Lynn A Sleeper; Girish Shirali; Piers Barker; Charles E Canter; Karen Altmann; Elizabeth Radojewski; Elif Seda Selamet Tierney; Jack Rychik; Lloyd Y Tani
Journal:  Circ Heart Fail       Date:  2013-10-16       Impact factor: 8.790

6.  Intramuscular injection of human umbilical cord-derived mesenchymal stem cells improves cardiac function in dilated cardiomyopathy rats.

Authors:  Chenggang Mao; Xu Hou; Benzhen Wang; Jingwei Chi; Yanjie Jiang; Caining Zhang; Zipu Li
Journal:  Stem Cell Res Ther       Date:  2017-01-28       Impact factor: 6.832

7.  The mutations associated with dilated cardiomyopathy.

Authors:  Ruti Parvari; Aviva Levitas
Journal:  Biochem Res Int       Date:  2012-07-09

Review 8.  Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.

Authors:  Marco Francone
Journal:  ISRN Radiol       Date:  2014-02-04

Review 9.  Application of Neonatologist Performed Echocardiography in the Assessment and Management of Neonatal Heart Failure unrelated to Congenital Heart Disease.

Authors:  Philip T Levy; Cecile Tissot; Beate Horsberg Eriksen; Eirik Nestaas; Sheryle Rogerson; Patrick J McNamara; Afif El-Khuffash; Willem P de Boode
Journal:  Pediatr Res       Date:  2018-07       Impact factor: 3.756
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.